About The Study: In this randomized clinical trial of major depressive disorder, a single dose of psilocybin was associated with rapid antidepressant effects, observed by day 2 and persisting for more than 3 months on secondary outcomes; psilocybin was generally well tolerated, but some individuals required additional support after dosing due to anxiety. These results suggest that psilocybin may provide a rapid and relatively long-lasting antidepressant effect on major depressive disorder, warranting further investigation into repeated dosing or adjunctive treatment strategies.

A new study published in ACS Nutrition Science suggests that eating grapes may provide broader skin health benefits than previously understood. Earlier clinical trials found that grape consumption helped increase the skin’s resilience to UV exposure in roughly 30–50% of participants. The latest research indicates those benefits may extend more widely across the population, suggesting grapes could positively influence skin health in nearly everyone.

The Flow Cytometry Resource (FCR), part of the Center for Advanced Research Technologies (CART) at University of Rochester Medicine, has been selected for the 2026 class of Recognized Shared Resource Laboratories by the International Society for the Advancement of Cytometry (ISAC). This prestigious designation highlights the facility’s sustained excellence in operations and its adherence to internationally recognized best practices in cytometry. Notably, it is the only academic medical center laboratory recognized in this cycle.

A new report underscores the significant variations in healthfulness of different types of processed foods. The report, released by Healthy Eating Research (HER), recommends that “healthy” ultra-processed foods be exempt from policies meant to discourage consumers from eating them. 

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.